• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechCancer research

Everything You Need to Know About the White House’s Cancer Moonshot

By
Hilary Brueck
Hilary Brueck
Down Arrow Button Icon
By
Hilary Brueck
Hilary Brueck
Down Arrow Button Icon
February 1, 2016, 4:12 PM ET
Preparations For The World Economic Forum (WEF) 2016
U.S. Vice President Joseph "Joe" Biden speaks during a panel session on cancer research, treatment and data science in Davos, Switzerland, on Tuesday, Jan. 19, 2016. World leaders, influential executives, bankers and policy makers attend the 46th annual meeting of the World Economic Forum in Davos from Jan. 20 - 23. Photographer: Jason Alden/Bloomberg *** Local Caption *** Joe BidenJason Alden—Bloomberg via Getty Images

The White House Cancer Moonshot Task Force had its first official meeting today, making clearer the details behind the initiative President Obama introduced in his annual State of the Union address last month.

Dubbed a “moonshot” without the trip to space, the sky-high effort is essentially a re-doubled cancer research push, aimed at accomplishing in the next five years what would normally take ten. Headed by Vice President Biden, the effort aims to better coordinate cancer lab research and clinical data from around the country—while cutting down on unnecessary bureaucracy.

The $1 billion initiative begins immediately with $195 million in funding for the National Institutes of Health this year. But President Obama’s proposed 2017 budget, which he’ll submit to Congress next week, would add $755 million to that sum next year for more cancer research at both the NIH and the FDA.

According to a Medium post written by Vice President Biden introducing the task force, some of the team’s top priorities include:

  • Speeding up access to cancer databases for doctors and researchers,
  • Opening up clinical trials, and
  • Applying the funding so that “some of the best work going on has the funding that it needs.”

Get Data Sheet, Fortune’s technology newsletter.

So, what might 10 years of research packed into five look like? Some of the biggest cancer research breakthroughs in the past decade have included:

  • More than 60 FDA-approved anti-cancer drugs, with 14 approved in 2015,
  • A National Institutes of Health Cancer Genome Atlas that has sequenced tumor samples from 33 different types of cancer, and
  • A first-of-its-kind cancer vaccine that can prevent cervical cancer.

 

But as Fortune’s Clifton Leaf argues, much of what’s needed to boost today’s cancer research may be, like the trip to the moon, a question of building the right infrastructure. This would involve creating new tools for classifying and organizing cancer data and developing more streamlined systems for sharing research. But also, only 5% of today’s cancer patients are enrolled in clinical trials, and obstacles to participation will need to be reduced.

President Obama wants the U.S. to cure cancer:

As a father who lost his eldest son Beau to brain cancer last year, Biden’s fight is not all politics.

“I want you to know that I’ll be focusing the rest of the time I have in office — and the rest of my life — on this effort,” Biden wrote.

The task force’s first recommendations, set to be publicly available online, are due at the end of 2016.

On Feb. 2, this story was edited to note that the task force was not yet backed by $1 billion, but it would be if the President’s 2017 budget is approved.

About the Author
By Hilary Brueck
See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Tech

A smartphone displaying the Google Gemini logo.
AIEye on AI
As ‘agentic commerce’ gains ground, companies shouldn’t put too much faith in ‘GEO,’ one industry insider warns
By Jeremy KahnJanuary 13, 2026
3 hours ago
AIChatbots
Being mean to ChatGPT can boost its accuracy, but scientists warn you may regret it
By Marco Quiroz-GutierrezJanuary 13, 2026
4 hours ago
AIGoldman Sachs Group
‘Humans could go the way of horses’: Goldman calculated how bad the AI ‘job apocalypse’ will be—and its analysts were pleasantly surprised
By Jim EdwardsJanuary 13, 2026
5 hours ago
Mark Zuckerberg
Future of WorkMeta
Meta is changing its performance review to reward output over effort, taking a page from Amazon and X
By Jake AngeloJanuary 13, 2026
5 hours ago
Warren Buffett on the phone
SuccessProductivity
Gen X CEO uses AI versions of Steve Jobs and Warren Buffett as a ‘fantasy board of directors’ to help him prepare for meetings and performance reviews
By Preston ForeJanuary 13, 2026
5 hours ago
Mercor Founders - Adarsh Hiremath, Brendan Foody
AIskills
Chief people officers—and Jamie Dimon—say AI can’t learn ‘human skills.’ The world’s youngest self-made billionaires want to prove them wrong
By Jake AngeloJanuary 13, 2026
6 hours ago

Most Popular

placeholder alt text
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30 billion from a year prior
By Eleanor PringleJanuary 12, 2026
1 day ago
placeholder alt text
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By Jim EdwardsJanuary 12, 2026
1 day ago
placeholder alt text
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By Jordan BlumJanuary 13, 2026
12 hours ago
placeholder alt text
Tech
Elon Musk asked people to upload their medical data to X so his AI company could learn to interpret MRIs and CT scans
By Sasha RogelbergJanuary 11, 2026
2 days ago
placeholder alt text
Success
An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually ‘pushing us to get better’
By Emma BurleighJanuary 10, 2026
3 days ago
placeholder alt text
Economy
The longer the Supreme Court delays its tariff decision, the better it is for President Trump
By Jim EdwardsJanuary 13, 2026
11 hours ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.